RAB27A and glioma: Since cathepsin D is a normal and major component of lysosomes, frequently used as a marker [22], these results confirm that the mechanism by which RNAi-Rab27a inhibits glioma invasion is by inhibiting lysosomal exocytosis of cathepsin D or the extracellular release of other lysosomal enzymes.